Karl Frederic Reps Critical Care Immunotherapy Company in Life Science and Office Lease
Karl Frederic represented CytoSorbents Corp. as the tenant in its lease of 48,000sf of life science and office space in the Greater Princeton locale of Plainsboro, NJ. CytoSorbents intends to eventually consolidate its operations under its new roof, including R&D, new product launches and assembly, as well as administration. The principal technology developed by CytoSorbents has been granted emergency use authorization by the Food & Drug Administration for the treatment of COVID-19. Read the article.
Karl’s practice has a particular focus on real estate matters involving the pharmaceutical and bio-tech industries. He has provided services to global technology firms, pharmaceutical conglomerates, educational institutions and healthcare companies. He also advises clients on acquisitions and the repositioning and expansion of pharmaceutical and healthcare campuses.